AIM ImmunoTech Inc.

AIM · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances)
364
SEC Filings

Business Summary

PART I GENERAL AIM ImmunoTech Inc. and its subsidiaries are an immuno-pharma company headquartered in Ocala, Florida, and focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases and immune-deficiency disorders for which there are inadequate or unmet therapies. We have established a strong foundation of laboratory, pre-clinical and clinical data with respect to the development of nucleic acids and natural interferon to enhance the natural antivir...

Next Earnings

Q2 FY2026 — expected 2026-07-28

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAIMdiscussed_in_filing Cybersecurity
topic_mentionAIMdiscussed_in_filing Trusted Computing
topic_mentionAIMdiscussed_in_filing Blockchain & Crypto
topic_mentionAIMdiscussed_in_filing Regulation
topic_mentionAIMdiscussed_in_filing Healthcare & Bio
topic_mentionAIMdiscussed_in_filing Sovereign & Government
topic_mentionAIMdiscussed_in_filing Cybersecurity
topic_mentionAIMdiscussed_in_filing Trusted Computing
topic_mentionAIMdiscussed_in_filing Blockchain & Crypto
topic_mentionAIMdiscussed_in_filing Regulation
topic_mentionAIMdiscussed_in_filing Healthcare & Bio
topic_mentionAIMdiscussed_in_filing Sovereign & Government
topic_mentionAIMdiscussed_in_filing Cybersecurity
topic_mentionAIMdiscussed_in_filing Trusted Computing
topic_mentionAIMdiscussed_in_filing Blockchain & Crypto
topic_mentionAIMdiscussed_in_filing Regulation
topic_mentionAIMdiscussed_in_filing Healthcare & Bio
topic_mentionAIMdiscussed_in_filing Sovereign & Government
topic_mentionAIMdiscussed_in_filing Cybersecurity
topic_mentionAIMdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001493152-26-013301EDGAR84K words
2025-03-272024-12-310001641172-25-000847EDGAR—
2024-04-012023-12-310001493152-24-012058EDGAR—
2023-03-312022-12-310001493152-23-010351EDGAR—
2022-03-312021-12-310001493152-22-008324EDGAR—
2021-03-312020-12-310001493152-21-007259EDGAR—
2020-03-302019-12-310001493152-20-005290EDGAR—
2019-04-012018-12-310001493152-19-004583EDGAR—
2018-03-302017-12-310001493152-18-004291EDGAR—
2017-03-312016-12-310001493152-17-003242EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-172025-09-300001493152-25-023894EDGAR37K words
2025-08-142025-06-300001493152-25-011986EDGAR—
2025-05-152025-03-310001641172-25-011033EDGAR—
2024-11-142024-09-300001493152-24-045971EDGAR—
2024-08-142024-06-300001493152-24-032355EDGAR—
2024-05-152024-03-310001493152-24-019917EDGAR—
2023-11-142023-09-300001493152-23-041294EDGAR—
2023-08-142023-06-300001493152-23-028610EDGAR—
2023-05-152023-03-310001493152-23-016763EDGAR—
2022-11-142022-09-300001493152-22-032118EDGAR—
2022-08-152022-06-300001493152-22-022600EDGAR—
2022-05-132022-03-310001493152-22-013341EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-060001493152-26-009190EDGAR21K words
2026-02-050001493152-26-005208EDGAR—
2026-01-200001493152-26-002728EDGAR—
2026-01-120001493152-26-001898EDGAR—
2025-12-170001493152-25-028156EDGAR—
2025-11-190001493152-25-024156EDGAR—
2025-10-290001493152-25-020102EDGAR—
2025-10-200001493152-25-018583EDGAR—
2025-07-310001641172-25-021762EDGAR—
2025-07-280001493152-25-011441EDGAR—

364 total filings indexed. 332 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc. ABOS — Acumen Pharmaceuticals, Inc.

Company Identity

CIK0000946644
TickerAIM
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f06c524568c4c5e133c18993213a8741e1fc2855eb24c37263c2957bedc8d841
parent: e89dfa0d4416f35d61043e6fcfe72c3451e6725d9c6c7a5f05083626b66dd370
content hash: a92a4bab39bb00492f512cb59d72737d62d13e9c0586f77f999bdc728ed5523d
signed: 2026-04-13T04:43:32.872Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf